Counterfeit in Pharmaceutical sector is a growing problem in both scope and scale. For example, the World Health Organization (WHO) estimates that over 30% of pharmaceuticals in developing countries are counterfeit. Pharmaceutical companies get into risk with the counterfeiting problems as it negatively impacts their brand reputation and diminishes returns on new drug development. Equally important are the health risks at both the patient and population levels. While a counterfeit pharmaceutical can have different effects on a consumer or patient, counterfeits pharmaceuticals also introduce various public health risks. For example, patients can lose trust in health care providers when counterfeits are very publically discovered in established pharmaceutical supply chains.
This session by Douglas C. Moyer, PhD, CPP will provide participants a full understanding of counterfeit pharmaceuticals including the various types of counterfeiting along with their unique effects on patients and populations. This awareness will enable practitioners, health care officials, and pharmaceutical companies to adopt anti-counterfeiting strategies that include effective and efficient tactics. This will improve the public's health and better protect brand owners' current and future profits.
The lure of huge profits through counterfeiting is eroding the pharmaceutical companies' traditional return-on-development business case. Simultaneously, counterfeit pharmaceuticals pose a growing public health threat. Risks are compounded by patients and consumers that unknowingly - or otherwise, acquire pharmaceuticals through rogue internet pharmacies. Gain knowledge now to better prepare for the global battle to protect the public's health and profits.
Who Should Attend:
- Dr. David Lim
Dr. Moyer is an Assistant Professor in Michigan State University’s Program In Public Health (College of Human Medicine) since 2009. He teaches and develops online graduate-level courses including Public Health Administration and the Public Health Risks from Counterfeit Pharmaceuticals. These courses are also core requirements for the program's various Graduate Certificates.